DengiAll Vaccine Safety Concerns: 42 Severe Adverse Events in Brazil’s Butantan-DV Campaign, Risk of Antibody-Dependent Enhancement

AI-powered VMTB Tool Boosts TB Detection by 251% in Haryana Under National TB Elimination Programme

A new AI-powered vulnerability mapping tool (VMTB) under the National TB Elimination Programme has significantly increased TB case detection efficiency, achieving a 251% relative increase in yield in Haryana. It uses geospatial data to pinpoint high-risk areas, enabling targeted screening and early diagnosis, crucial for India's fight against TB.

US FDA Approves India-Discovered Antibiotic Zaynich, Aims to Combat AMR with Indian Data

The US FDA's approval of the novel antibiotic Zaynich, discovered and developed in India, marks a major shift for the Indian pharmaceutical sector. It moves beyond generic manufacturing to showcase high-risk drug discovery capabilities. This is crucial as India bears a disproportionate burden of Antimicrobial Resistance (AMR), and the drug's development used data from Indian healthcare settings.

ICMR's PreVenTB Trial Shows VPM1002 Vaccine with 50.4% Efficacy Against Extrapulmonary TB, Targets Elimination by 2030

ICMR's landmark PreVenTB trial provides crucial data on new TB vaccines, showing significant efficacy against hard-to-diagnose extrapulmonary TB. This offers a pragmatic tool for India's ambitious TB elimination target, requiring a shift from waiting for a perfect vaccine to deploying layered public health strategies.

Supreme Court Seeks AIIMS Expert Opinion on EEG, Angiogram Tests for Brain Death Certification Under NOTTO Guidelines

The Supreme Court is reviewing the brain death certification protocol, seeking expert opinion on adding confirmatory tests like EEG and angiogram. This has major implications for deceased organ donation rates in India, which currently stands at a low 0.77 per million population. The case highlights gaps in medical training and protocol adherence, making it crucial for governance and health policy aspirants.

ICMR Restructures Institutes into Interdisciplinary Hubs, Launches National Health Research Programme with 13 Priority Areas

The Indian Council of Medical Research (ICMR) is undergoing a major strategic transformation to align with national health goals for Viksit Bharat 2047. The reforms include restructuring institutes into interdisciplinary hubs, creating regional National Institutes of Health Research, and launching the National Health Research Programme targeting 13 priority areas, all aimed at creating an anticipatory and innovation-driven health ecosystem.

RTS,S Malaria Vaccine Reduces Child Mortality by 13% in Africa; India Aims for Zero Indigenous Cases by 2027

A landmark Lancet study confirms the RTS,S/AS01E malaria vaccine reduced all-cause child mortality by 13% in African pilot countries, validating vaccine-based prevention. While India has made significant progress, exiting WHO's High Burden to High Impact group in 2024, it now targets zero indigenous malaria cases by 2027 and nationwide elimination by 2030.

Bundibugyo Ebola Outbreak Exposes Vaccine Gap for NTDs; WHO Declares PHEIC; 25-90% Mortality Rate

The Bundibugyo ebolavirus outbreak in DRC and Uganda, declared a PHEIC by WHO, highlights systemic neglect of vaccine R&D for Neglected Tropical Diseases (NTDs). The absence of a licensed vaccine underscores market failures and infrastructure gaps, as diseases affecting poorer regions lack commercial incentives, despite high mortality rates of 25-90%.

India Urged to Form 'Defensive AI Quad', Establish AI Safety Institute with ₹20,000 Cr Fund Amid Claude Mythos Cyber Threat

A new AI model, Claude Mythos, poses a significant threat by autonomously discovering and exploiting critical cybersecurity vulnerabilities. This necessitates urgent Indian action, including forming an international 'Defensive AI Quad' with the US, UK, and Japan, establishing a dedicated AI Safety Institute, and creating a large cybersecurity fund to secure legacy systems.